--2025/Q2-- / 1.429M--
--2025/Q1-- / 873.440K--
Mar 5, 20252024/Q430.604M / 37.171M--
--2024/Q361.000K / 3.894M--
Aug 7, 20242024/Q2513.000K / 4.142M--
Alibaba
BABA
Tesla
TSLA
NVIDIA
NVDA
ASML Holding
ASML
Amazon
AMZN
US Stock MarketDetailed Quotes
EDIT Editas Medicine
- 1.515
- -0.045-2.88%
Trading Mar 11 09:37 ET
125.71MMarket Cap-0.53P/E (TTM)
1.580High1.480Low209.88KVolume1.570Open1.560Pre Close315.29KTurnover0.25%Turnover RatioLossP/E (Static)82.98MShares8.44052wk High0.94P/B125.22MFloat Cap1.12052wk Low--Dividend TTM82.65MShs Float99.950Historical High--Div YieldTTM6.41%Amplitude1.120Historical Low1.502Avg Price1Lot Size
Editas Medicine Key Stats
Editas Medicine Q4 2024 Earnings Date
Currency：USDMar 5, 2025
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 37.17M | 30.60M | -6.57M |
| Miss Est. | -38.10% | -49.03% | -17.67% |
| EPS | -0.35 | -0.55 | -0.20 |
| Miss Est. | -52.50% | -139.13% | -56.87% |
Analyst Rating
Mar 11, 2025
Editas Medicine Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Editas Medicine Earnings Reports
Read more
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data
